These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

675 related items for PubMed ID: 18093447

  • 1. A systematic review and economic model of switching from non-glycopeptide to glycopeptide antibiotic prophylaxis for surgery.
    Cranny G, Elliott R, Weatherly H, Chambers D, Hawkins N, Myers L, Sculpher M, Eastwood A.
    Health Technol Assess; 2008 Jan; 12(1):iii-iv, xi-xii, 1-147. PubMed ID: 18093447
    [Abstract] [Full Text] [Related]

  • 2. An economic model for the prevention of MRSA infections after surgery: non-glycopeptide or glycopeptide antibiotic prophylaxis?
    Elliott RA, Weatherly HL, Hawkins NS, Cranny G, Chambers D, Myers L, Eastwood A, Sculpher MJ.
    Eur J Health Econ; 2010 Feb; 11(1):57-66. PubMed ID: 19669182
    [Abstract] [Full Text] [Related]

  • 3. Glycopeptide vs. non-glycopeptide antibiotics for prophylaxis of surgical site infections: a systematic review.
    Chambers D, Worthy G, Myers L, Weatherly H, Elliott R, Hawkins N, Sculpher M, Eastwood A.
    Surg Infect (Larchmt); 2010 Oct; 11(5):455-62. PubMed ID: 20815758
    [Abstract] [Full Text] [Related]

  • 4. Antibiotic prophylaxis for the prevention of methicillin-resistant Staphylococcus aureus (MRSA) related complications in surgical patients.
    Gurusamy KS, Koti R, Wilson P, Davidson BR.
    Cochrane Database Syst Rev; 2013 Aug 19; 2013(8):CD010268. PubMed ID: 23959704
    [Abstract] [Full Text] [Related]

  • 5. Impact of methicillin-resistant Staphylococcus aureus prevalence among S. aureus isolates on surgical site infection risk after coronary artery bypass surgery.
    Miller LG, McKinnell JA, Vollmer ME, Spellberg B.
    Infect Control Hosp Epidemiol; 2011 Apr 19; 32(4):342-50. PubMed ID: 21460485
    [Abstract] [Full Text] [Related]

  • 6. A cost-effectiveness modelling study of strategies to reduce risk of infection following primary hip replacement based on a systematic review.
    Graves N, Wloch C, Wilson J, Barnett A, Sutton A, Cooper N, Merollini K, McCreanor V, Cheng Q, Burn E, Lamagni T, Charlett A.
    Health Technol Assess; 2016 Jul 19; 20(54):1-144. PubMed ID: 27468732
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness of a bundled intervention of decolonization and prophylaxis to decrease Gram positive surgical site infections after cardiac or orthopedic surgery: systematic review and meta-analysis.
    Schweizer M, Perencevich E, McDanel J, Carson J, Formanek M, Hafner J, Braun B, Herwaldt L.
    BMJ; 2013 Jun 13; 346():f2743. PubMed ID: 23766464
    [Abstract] [Full Text] [Related]

  • 8. Does surgical prophylaxis with teicoplanin constitute a therapeutic advance?
    Mini E, Nobili S, Periti P.
    J Chemother; 2000 Nov 13; 12 Suppl 5():40-55. PubMed ID: 11131963
    [Abstract] [Full Text] [Related]

  • 9. Multicentre randomised double-blind placebo controlled trial of combination vancomycin and cefazolin surgical antibiotic prophylaxis: the Australian surgical antibiotic prophylaxis (ASAP) trial.
    Peel T, Astbury S, Cheng AC, Paterson D, Buising K, Spelman T, Tran-Duy A, de Steiger RS, ASAP Trial Group.
    BMJ Open; 2019 Nov 03; 9(11):e033718. PubMed ID: 31685516
    [Abstract] [Full Text] [Related]

  • 10.
    Desser AS, Arentz-Hansen H, Fagerlund BF, Harboe I, Lauvrak V.
    ; 2017 08 25. PubMed ID: 29553663
    [Abstract] [Full Text] [Related]

  • 11. Review of MRSA screening and antibiotics prophylaxis in orthopaedic trauma patients; The risk of surgical site infection with inadequate antibiotic prophylaxis in patients colonized with MRSA.
    Iqbal HJ, Ponniah N, Long S, Rath N, Kent M.
    Injury; 2017 Jul 25; 48(7):1382-1387. PubMed ID: 28473167
    [Abstract] [Full Text] [Related]

  • 12. Clinical consequences and cost of limiting use of vancomycin for perioperative prophylaxis: example of coronary artery bypass surgery.
    Zanetti G, Goldie SJ, Platt R.
    Emerg Infect Dis; 2001 Jul 25; 7(5):820-7. PubMed ID: 11747694
    [Abstract] [Full Text] [Related]

  • 13. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
    Forbes C, Shirran L, Bagnall AM, Duffy S, ter Riet G.
    Health Technol Assess; 2001 Jul 25; 5(28):1-110. PubMed ID: 11701100
    [Abstract] [Full Text] [Related]

  • 14. Risk of surgical site infection, acute kidney injury, and Clostridium difficile infection following antibiotic prophylaxis with vancomycin plus a beta-lactam versus either drug alone: A national propensity-score-adjusted retrospective cohort study.
    Branch-Elliman W, Ripollone JE, O'Brien WJ, Itani KMF, Schweizer ML, Perencevich E, Strymish J, Gupta K.
    PLoS Med; 2017 Jul 25; 14(7):e1002340. PubMed ID: 28692690
    [Abstract] [Full Text] [Related]

  • 15. Dual Antibiotic Prophylaxis in Total Knee Arthroplasty: Where Do We Stand?
    Villa JM, Pannu TS, Riesgo AM, Patel PD, Mont MA, Higuera-Rueda CA.
    J Knee Surg; 2020 Feb 25; 33(2):100-105. PubMed ID: 31470454
    [Abstract] [Full Text] [Related]

  • 16. Colonization with methicillin-resistant Staphylococcus aureus in ICU patients: morbidity, mortality, and glycopeptide use.
    Garrouste-Orgeas M, Timsit JF, Kallel H, Ben Ali A, Dumay MF, Paoli B, Misset B, Carlet J.
    Infect Control Hosp Epidemiol; 2001 Nov 25; 22(11):687-92. PubMed ID: 11842988
    [Abstract] [Full Text] [Related]

  • 17. Comparison of routine prophylaxis with vancomycin or cefazolin for femoral neck fracture surgery: microbiological and clinical outcomes.
    Merrer J, Desbouchages L, Serazin V, Razafimamonjy J, Pauthier F, Leneveu M.
    Infect Control Hosp Epidemiol; 2006 Dec 25; 27(12):1366-71. PubMed ID: 17152036
    [Abstract] [Full Text] [Related]

  • 18. Cost-effectiveness of linezolid and vancomycin in the treatment of surgical site infections.
    Patanwala AE, Erstad BL, Nix DE.
    Curr Med Res Opin; 2007 Jan 25; 23(1):185-93. PubMed ID: 17257479
    [Abstract] [Full Text] [Related]

  • 19. Vancomycin for surgical prophylaxis?
    Crawford T, Rodvold KA, Solomkin JS.
    Clin Infect Dis; 2012 May 25; 54(10):1474-9. PubMed ID: 22328468
    [Abstract] [Full Text] [Related]

  • 20. Methicillin-resistant staphylococci in clean surgery. Is there a role for prophylaxis?
    Mini E, Nobili S, Periti P.
    Drugs; 1997 May 25; 54 Suppl 6():39-52. PubMed ID: 9474480
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.